In order to verify the effect of NR2F6 on the proliferation of lung cancer cells, a CCK8 kit was used to detect the proliferation of H460 cells in the untreated group (non-transfected mock group), the NR2F6 negative control group (shNC group), and the NR2F6 stable knockdown groups (shNR2F6#1, shNR2F6#3). The gene discussed is NR2F6; the disease is lung carcinoma.